NorthRock Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,826
Closed -$774K 860
2025
Q3
$774K Buy
2,826
+81
+3% +$22.1K 0.01% 407
2025
Q2
$708K Buy
2,745
+163
+6% +$38.9K 0.02% 314
2025
Q1
$578K Buy
2,582
+132
+5% +$30.8K 0.02% 317
2024
Q4
$560K Sell
2,450
-682
-22% -$164K 0.02% 330
2024
Q3
$765K Sell
3,132
-47
-1% -$10.5K 0.03% 261
2024
Q2
$609K Buy
3,179
+322
+11% +$65.3K 0.02% 298
2024
Q1
$566K Buy
2,857
+55
+2% +$10.1K 0.02% 327
2023
Q4
$482K Buy
2,802
+1,328
+90% +$204K 0.02% 330
2023
Q3
$218K Buy
1,474
+467
+46% +$84.4K 0.02% 315
2023
Q2
$220K Sell
1,007
-159
-14% -$35.4K 0.02% 275
2023
Q1
$255K Sell
1,166
-41
-3% -$8.89K 0.03% 261
2022
Q4
$251K Sell
1,207
-109
-8% -$23.9K 0.03% 285
2022
Q3
$287K Buy
1,316
+152
+13% +$34.6K 0.03% 210
2022
Q2
$244K Buy
1,164
+255
+28% +$54.3K 0.03% 258
2022
Q1
$220K Buy
909
+126
+16% +$30.5K 0.02% 303
2021
Q4
$204K Buy
783
+15
+2% +$3.89K 0.02% 316
2021
Q3
$202K Buy
+768
New +$210K 0.02% 271
2020
Q3
Sell
-1,042
Closed -$200K 233
2020
Q2
$200K Buy
+1,042
New +$170K 0.02% 201
2020
Q1
Sell
-1,555
Closed -$241K 265
2019
Q4
$241K Buy
1,555
+45
+3% +$6.49K 0.03% 230
2019
Q3
$204K Buy
+1,510
New +$198K 0.03% 198

Other funds holding RMD

NorthRock Partners's RMD Position: Q4 2025 in Review

NorthRock Partners sold out of ResMed (RMD) in Q4 2025, closing a stake of 2,826 shares — an estimated $774K sold.

NorthRock Partners first reported a position in RMD in Q3 2019 and held it in 20 quarters. The position peaked at $774K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • NorthRock Partners reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • NorthRock Partners sold 2,826 ResMed shares in Q4 2025, an estimated $774K.
  • NorthRock Partners first reported a position in ResMed in Q3 2019 and held it in 20 quarters.
  • NorthRock Partners's ResMed position peaked at $774K in Q3 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.